Effect of probiotic versus placebo on non-bacterial infections of the upper respiratory system in infants

Effect of probiotic versus placebo on non-bacterial infections of the upper respiratory system in infants: a double-blind randomized clinical trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20120215009014N521

Enrollment

450

Registered

2024-08-14

Start date

2024-09-15

Completion date

Unknown

Last updated

2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-bacterial infections of the upper respiratory system. Disease of upper respiratory tract, unspecified

Interventions

Intervention 1: Intervention group: Routine treatment plus feeding 100 ml of pasteurized fermented milk containing LGG at a dose of 109 units through a milk bottle twice a day for one week. Interventi

Eligibility

Sex/Gender

All

Age

6 Months to 12 Months

Inclusion criteria

Inclusion criteria: Infants 6 to 12 months Nonbacterial upper respiratory tract inflammation

Exclusion criteria

Exclusion criteria: Respiratory tract infection Immune system defect

Design outcomes

Primary

Measure	Time frame
Severity and duration of clinical signs and symptoms of non-bacterial upper respiratory system infections. Timepoint: Before the intervention and one week later. Method of measurement: By taking history and clinical examination.;Duration of hospitalization. Timepoint: After the intervention. Method of measurement: By examining the patient's medical record.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmir Mohammad Khorsandi Nejad

Hamedan University of Medical Sciences

amirkhorsandi1997@gmail.com+98 81 3838 0572

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026